Rhythmic Light Therapy for Alzheimer's Disease Patients
NCT: NCT05015478 · COMPLETED
Brief Summary
The investigator will investigate how light delivering 40 hertz (Hz) affects subjective sleep and cognition in a controlled laboratory study. A lab study will allow the collection of electroencephalogram (EEG) data, perform cognitive tests, and observe the response in those with mild cognitive impairment (MCI) compared to a healthy control group (HC). Participants will attend two study sessions over the course of two weeks. During both sessions, all participants will experience 10 minutes of a low-level light, followed by a data collection period which involves a sleepiness rating, an electroencephalogram (EEG) recording, and a computerized memory test. Participants will then experience either a RL or a placebo RL condition for one hour, after which there will be a second data collection.
Frequently Asked Questions
What is Rhythmic Light Therapy for Alzheimer's Disease Patients?
Rhythmic Light Therapy for Alzheimer's Disease Patients is a clinical trial registered under NCT05015478. Current status: COMPLETED.
What is the status of NCT05015478?
The current status of NCT05015478 (Rhythmic Light Therapy for Alzheimer's Disease Patients) is: COMPLETED.
When did Rhythmic Light Therapy for Alzheimer's Disease Patients start?
Rhythmic Light Therapy for Alzheimer's Disease Patients started on 2022-01-10.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.